Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @FAndreMD
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FAndreMD
-
FabriceAndre proslijedio/la je Tweet
With Europe’s beating Cancer Plan we can make a difference together:
With prevention and research
With equal access across Europe
Standing at the side of those who need us.
#EUCancerPlanpic.twitter.com/utjjaKWc3A
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The minister of health
@agnesbuzyn visited@GustaveRoussy today. A good opportunity to discuss survivorship, early detection, AI, innovation and in general how to integrate research and innovation in daily care.https://twitter.com/agnesbuzyn/status/1224643162699976704 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
precision medicine is "just" the concept behind endocrine therapy and trastuzumab in breast cancer, two drugs that cure several 100 000's live a year. I would not call this paper a "reality check on PM" but a "personal opinion on genomics"...https://twitter.com/muinjkhoury/status/1224026685173043205 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
best start for a weekhttps://twitter.com/ogcnice/status/1224061027471495169 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FabriceAndre proslijedio/la je Tweet
Fantastic article just published in
@nature by Ben Deneen’s lab@BaylorMedicine focused on glioma hyper excitability and new synapse formation through PIK3CA variantshttps://www.nature.com/articles/d41586-020-00137-x …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FabriceAndre proslijedio/la je Tweet
#bcsm This paper describing the clinical presentation, outcomes and mutational landscape of ER+/HER2- & triple-negative metastatic#BreastCancer harboring PIK3CA mutations from SAFIR02 highlights the potential for new drug development https://www.annalsofoncology.org/article/S0923-7534(19)39094-5/abstract …@fermosele@FAndreMDpic.twitter.com/DTXf0LMEJt
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FabriceAndre proslijedio/la je Tweet
Single-cell nucleic acid sequencing has become an essential biomedical research tool. Now
@slavovLab@Northeastern makes a strong case that single-cell proteomics will yield another dimension of vital insights https://science.sciencemag.org/content/367/6477/512/tab-pdf …@ScienceMagazine w/@ScienceVisualspic.twitter.com/3H2HKQj2nf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In this paper; investigators evaluate Raf inhibitor in V600E and non V600E mutant nsclc, and reinforce the concept that a companion diagnostic should meet a precise definition and not only "raf mutated" cancer.https://twitter.com/Annals_Oncology/status/1222119089067429888 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
3.5 M euros collected for the research on childhood cancers during the diner yesterday evening. Transformative results mandatory
@GustaveRoussy . Led by@Frederic_Lemos . Join the effort !https://twitter.com/GustaveRoussy/status/1222174798723325952 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FabriceAndre proslijedio/la je Tweet
Dr. Aurelien Marabelle presents KEYNOTE-158, second-line pembrolizumab in advanced anal squamous cell carcinoma. Median OS 11.9 months.
#GI20pic.twitter.com/mY86cT2seJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@AgenceRecherche will provide additional 4 M euros to CANTO: a. extend follow up of the 12000 pts >5y b. increase the nb of young pts c. create cohorts of patients treated w new drugs d. collect new sources of biosamples (feces...) the project should be sustainable in 4 yrsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In pts with HR+/HER2- mBC eligible to 1st line chemotherapy, PIK3CA mutation is associated with chemoresistance and a poor outcome. These data consolidate the unmet medical need https://www.annalsofoncology.org/#/article/S0923-7534(19)39094-5/fulltext …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FabriceAndre proslijedio/la je Tweet
In this study of sunscreen application by healthy pts, all 6 of the tested active ingredients administered in 4 sunscreen formulations were systemically absorbed and had plasma concentrations surpassing
@US_FDA thresholds for waiving safety studieshttps://ja.ma/3avshYPHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FabriceAndre proslijedio/la je Tweet
Our latest paper in Annals of Oncology found that after treatment for CIN women are still at increased risk of future cervical cancer, and also other HPV-related cancers. This risk remains elevated for 20+ years. https://www.sciencedirect.com/science/article/pii/S0923753419390854?via%3Dihub …
@ImperialMDR@ImperialSandCHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
I have the privilege to sit in a panel of
@CRUKresearch and it s truly amazing how people are professional, kind and how the process of grant selection is fair. Panels are always full of international experts. British colleagues and donnors can trust it.https://twitter.com/walker_CRUK/status/1220744134467694592 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Adjuvant bevacizumab in stage III colon cancer. https://www.annalsofoncology.org/?mobileUi=1#/article/S0923-7534(19)53229-X/fulltext …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FabriceAndre proslijedio/la je Tweet
Online
@nature: “The single-cell pathology landscape of breast cancer”https://www.nature.com/articles/s41586-019-1876-x …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
we must find solutions to make careers of clinician scientists more attractive. CS are the ones translating basic concepts and innovation to patients. need for action
@esmo@aacr@ASCO . V proud to sign this paper w@LoiSher@CRUKresearch@CharlesSwantonhttps://www.nature.com/articles/s43018-019-0005-y …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FabriceAndre proslijedio/la je Tweet
New ESMO consensus recommendations on 'Management of cardiac disease in #cancer pts throughout oncological treatment'
Read more on the prevention, detection & treatment of #cardiotoxicity http://ow.ly/FIgE50xYiHG@Annals_Oncology@E_de_Azambuja@curijoey#cardiovascularpic.twitter.com/ePuN2EzjgZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Important paper. 2 key concepts: the axes of health data and the "deep cohorts". Deep cohorts should be considered by research agencies when it's about addressing questions that require multidimensional data (+ deep cohorts can be meta-analyzed and include a small control arm) https://twitter.com/segal_eran/status/1217530912407158785 …pic.twitter.com/WgqUQRgm2q
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

L'Album photos de la victoire sur l'OL est en ligne.